ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Noramco Announces Submission of Drug Master File for Lisdexamfetamine Dimesylate
December 06, 2021Noramco, LLC, a leading North American producer of controlled substance bulk Active Pharmaceutical Ingredients (APIs) for the pharmaceutical industry, today announced it has submitted a Type II Drug Master File (DMF) to the U.S. Food and Drug... -
Noramco, SPI Pharma Announce Availability of Excipient Compatibility Study for Cannabidiol Solid Oral Dosage Forms
July 10, 2019Noramco and SPI Pharma announced they have completed work on an excipient compatibility study examining a range of options for the development of cannabidiol (CBD) solid oral dosage forms ... -
Partnership struck to increase production of DEA controlled substances
March 19, 2018Noramco selects AFC for its infrastructure and analytical capabilities to help meet growing demand.
Pharma Sources Insight January 2025
